MEDICAL PROGRESS - HODGKINS-DISEASE

被引：227
作者：
URBA, WJ [1 ]
LONGO, DL [1 ]
机构：
[1] NCI, FREDERICK CANC RES & DEV CTR, BIOL RESPONSE MODIFIERS PROGRAM, FREDERICK, MD 21701 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 1992年 / 326卷 / 10期
关键词：
D O I：
10.1056/NEJM199203053261006
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：678 / 687
页数：10
相关论文
共 175 条
  • [1] AHMED T, 1989, LEUKEMIA, V3, P19
  • [2] INCREASED RISK OF SECONDARY ACUTE NONLYMPHOCYTIC LEUKEMIA AFTER EXTENDED-FIELD RADIATION-THERAPY COMBINED WITH MOPP CHEMOTHERAPY FOR HODGKINS-DISEASE
    ANDRIEU, JM
    IFRAH, N
    PAYEN, C
    FERMANIAN, J
    COSCAS, Y
    FLANDRIN, G
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (07) : 1148 - 1154
  • [3] ALLOGENEIC MARROW TRANSPLANTATION IN THE TREATMENT OF MOPP-RESISTANT HODGKINS-DISEASE
    APPELBAUM, FR
    SULLIVAN, KM
    THOMAS, ED
    BUCKNER, CD
    CLIFT, RA
    DEEG, HJ
    NEIMAN, PE
    SANDERS, JE
    STEWART, P
    STORB, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (11) : 1490 - 1494
  • [4] ARMITAGE JO, 1986, CANCER TREAT REP, V70, P871
  • [5] BANKS PM, 1990, SEMIN ONCOL, V17, P683
  • [6] BARTOLUCCI AA, 1983, CANCER, V52, P2209, DOI 10.1002/1097-0142(19831215)52:12<2209::AID-CNCR2820521206>3.0.CO
  • [7] 2-6
  • [8] BERGSAGEL DE, 1982, CANCER TREAT REP, V66, P717
  • [9] DECREASING RISK OF LEUKEMIA WITH PROLONGED FOLLOW-UP AFTER CHEMOTHERAPY AND RADIOTHERAPY FOR HODGKINS-DISEASE
    BLAYNEY, DW
    LONGO, DL
    YOUNG, RC
    GREENE, MH
    HUBBARD, SM
    POSTAL, MG
    DUFFEY, PL
    DEVITA, VT
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (12) : 710 - 714
  • [10] BONADONNA G, 1985, CANCER SURV, V4, P439
12345678910